GlassScriptPhysician profile
John Paul Barbara
NPI 1972882546
$8,623.83
in general payments reported to CMS, 2019-2025
35 companies · $2,087 in 2025
The $2,087 reported for 2025 was more than what 91% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,355 · 2022: $1,392 · 2023: $1,798 · 2024: $1,991 · 2025: $2,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,856 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,856.32 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,472.91 | 2021-2025 | Breztri, Airsupra, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,139.39 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $871.41 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $767.42 | 2021-2025 | Trelegy Ellipta, Arexvy, Bexsero |
| Amgen INC. | $741.43 | 2021-2025 | Repatha, Repatha, Otezla |
| Pfizer INC. | $585.69 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $408.69 | 2021-2023 | Januvia, Steglatro, Janumet |
| Abbvie INC. | $389.34 | 2021-2025 | |
| Lilly USA, LLC | $337.10 | 2021-2023 | Mounjaro, Jardiance, Emgality |
| Abbott Laboratories | $301.51 | 2022-2024 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $215.88 | 2022-2025 | |
| Amarin Pharma, INC. | $147.32 | 2021-2022 | |
| Mylan Specialty L.P. | $144.60 | 2023-2024 | Yupelri |
| Exact Sciences Corporation | $132.57 | 2023-2025 | Cologuard Collection Kit |
| Philips North America LLC | $120.21 | 2021-2025 | Vest Therapy Und, (8874) Incourage |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $88.74 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $85.69 | 2023-2024 | Nuedexta |
| Sanofi-Aventis U.S. LLC | $80.91 | 2021-2022 | |
| Viiv Healthcare Company | $66.04 | 2023-2024 | Apretude |
| Alfasigma USA, INC. | $56.91 | 2022 | |
| Xeris Pharmaceuticals, INC. | $55.61 | 2022-2023 | Gvoke Hypopen |
| Paratek Pharmaceuticals, INC. | $53.92 | 2025 | Nuzyra, Xhance |
| Avanir Pharmaceuticals, INC. | $51.71 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $50.54 | 2021-2025 | Zoryve |
| Heartflow, INC. | $35.87 | 2024 | |
| Dexcom, INC. | $33.36 | 2023 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $29.12 | 2021 | |
| Si-Bone, INC. | $29.11 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $25.08 | 2025 | Austedo Xr |
| Esperion Therapeutics, INC. | $24.01 | 2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $21.46 | 2023 | |
| Currax Pharmaceuticals LLC | $15.50 | 2025 | Contrave |
| Sanofi Pasteur INC. | $15.40 | 2023 | |
| Verity Pharmaceuticals INC. | $14.97 | 2025 | Tlando |
| Globus Medical, INC. | $14.41 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Barbara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.